发明名称 REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
摘要 PROBLEM TO BE SOLVED: To provide a technique, wherein an artificial induction technique of immunological tolerance against self or foreign antigen overcomes autoimmune disease, transplantation-related disorder, allergic responses, an immunological rejection of a therapeutic protein, and the like.SOLUTION: T cell epitopes (Tregitopes) that are capable of binding to major histocompatibility complex (MHC) molecules and engaging and activating natural T regulatory cells (TReg) are identified from a general self-protein, such as a constant region of IgG. The selective engagement and activation of Treg through the use of Tregitopes and Tregitope-antigen fusions are therapeutically valuable as a means of treatment for any disease or condition characterized by the presence of an unwanted immune response. Using as a vaccine delivery vector a Tregitope modified Fc which has been modified to no longer bind to MHC and Treg enables an efficient targeting of a vaccine antigen.
申请公布号 JP2014240404(A) 申请公布日期 2014.12.25
申请号 JP20140154372 申请日期 2014.07.30
申请人 EPIVAX INC 发明人 DE GROOT ANNE;MARTIN WILLIAM;RIVERA DAN
分类号 C07K14/47;A61K38/00;A61K39/00;A61P7/04;A61P15/08;A61P31/04;A61P31/12;A61P33/00;A61P35/00;A61P37/06;A61P37/08;A61P43/00;C07K7/04;C07K14/00;C12N15/09 主分类号 C07K14/47
代理机构 代理人
主权项
地址